Kundl, Austria

Johannes Raneburger

This inventor holds 5 USPTO granted patents and 6 published patent applications and 7 EPO patents. Top assignee: Sandoz Ag. Active years: 2016-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johannes Raneburger. Retrieved from https://idiyas.com/inventor/johannes-raneburger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Johannes Raneburger

Introduction

Johannes Raneburger is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on developing innovative compositions that enhance medical treatments.

Latest Patents

One of his latest patents is a pharmaceutical composition containing rifaximin alpha and delta. This invention relates to a pharmaceutical composition that includes rifaximin in the form of two different polymorphs, along with a method for preparing the same. Another significant patent is for a penicillin retard composition for intramuscular injection. This invention is directed towards an injection syringe that comprises an injectable composition containing penicillin, along with one or more pharmaceutically acceptable excipients and water, ensuring that the composition is free of a preservative agent.

Career Highlights

Johannes Raneburger is currently associated with Sandoz AG, a leading global healthcare company. His work at Sandoz AG has allowed him to focus on developing innovative pharmaceutical solutions that address various medical needs.

Collaborations

Throughout his career, Johannes has collaborated with talented professionals, including Heiko Degendorfer and Stefan Scheler. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Johannes Raneburger's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to impact the field positively, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…